Fulcrum Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Fulcrum Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Fulcrum Therapeutics Inc
Rating: 2.18333325
Author: Trendlyne DVM scores

about

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule ...

8.84 0.34 (4.00%)

New 52W High today

605.5K

XNAS Volume

XNAS 26 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.3 / 100

Technically Bullish

78.0 / 100

1Yr Price target upside is 25%

7 analysts

Fulcrum Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Fulcrum Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule ...

New 52W High today

SWOT Analysis

Fulcrum Therapeutics Inc Live Price Chart